These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 11850830)
1. Endonuclein is a cell cycle regulated WD-repeat protein that is up-regulated in adenocarcinoma of the pancreas. Honoré B; Baandrup U; Nielsen S; Vorum H Oncogene; 2002 Feb; 21(7):1123-9. PubMed ID: 11850830 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneous nuclear ribonucleoproteins F and H/H' show differential expression in normal and selected cancer tissues. Honoré B; Baandrup U; Vorum H Exp Cell Res; 2004 Mar; 294(1):199-209. PubMed ID: 14980514 [TBL] [Abstract][Full Text] [Related]
3. Retention of the fetoacinar pancreatic (FAP) protein to the endoplasmic reticulum of tumor cells. Miralles F; Langa F; Mazo A; Escribano MJ Eur J Cell Biol; 1993 Feb; 60(1):115-21. PubMed ID: 8462590 [TBL] [Abstract][Full Text] [Related]
4. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Ohuchida K; Mizumoto K; Ishikawa N; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M Clin Cancer Res; 2005 Nov; 11(21):7785-93. PubMed ID: 16278400 [TBL] [Abstract][Full Text] [Related]
5. The subcellular localization of syntaxin 17 varies among different cell types and is altered in some malignant cells. Zhang Q; Li J; Deavers M; Abbruzzese JL; Ho L J Histochem Cytochem; 2005 Nov; 53(11):1371-82. PubMed ID: 15956034 [TBL] [Abstract][Full Text] [Related]
6. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Maitra A; Adsay NV; Argani P; Iacobuzio-Donahue C; De Marzo A; Cameron JL; Yeo CJ; Hruban RH Mod Pathol; 2003 Sep; 16(9):902-12. PubMed ID: 13679454 [TBL] [Abstract][Full Text] [Related]
7. Transcriptional profiling of genes that are regulated by the endoplasmic reticulum-bound transcription factor AIbZIP/CREB3L4 in prostate cells. Ben Aicha S; Lessard J; Pelletier M; Fournier A; Calvo E; Labrie C Physiol Genomics; 2007 Oct; 31(2):295-305. PubMed ID: 17712038 [TBL] [Abstract][Full Text] [Related]
8. Analysis of c-kit protein expression in pancreatic neoplasms and its implication for prognosis. Kimura W; Ma J; Takeshita A; Yamamoto T; Moriya T; Hirai I; Fuse A Hepatogastroenterology; 2007 Dec; 54(80):2203-8. PubMed ID: 18265633 [TBL] [Abstract][Full Text] [Related]
9. [Down regulation of mitogen activated protein kinase phosphatase-1 mediate acquired multidrug resistance in pancreatic adenocarcinoma cell line SW1990/Fu]. Guo JC; Zhao YP; Liao Q; Chen G; Zhu Y Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):473-5. PubMed ID: 16772084 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of Bin1/Amphiphysin II in human tissues: diverse sites of nuclear expression and losses in prostate cancer. DuHadaway JB; Lynch FJ; Brisbay S; Bueso-Ramos C; Troncoso P; McDonnell T; Prendergast GC J Cell Biochem; 2003 Feb; 88(3):635-42. PubMed ID: 12532338 [TBL] [Abstract][Full Text] [Related]
11. Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma. Chen J; Xu J; Ying K; Cao G; Hu G; Wang L; Luo C; Lou M; Mao Y; Xie Y; Lu Y Gene; 2004 Sep; 340(1):61-9. PubMed ID: 15556295 [TBL] [Abstract][Full Text] [Related]
12. Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer. Roda O; Ortiz-Zapater E; Martínez-Bosch N; Gutiérrez-Gallego R; Vila-Perelló M; Ampurdanés C; Gabius HJ; André S; Andreu D; Real FX; Navarro P Gastroenterology; 2009 Apr; 136(4):1379-90, e1-5. PubMed ID: 19171142 [TBL] [Abstract][Full Text] [Related]
13. Amplification and overexpression of HER-2/neu in invasive ductal carcinomas of the pancreas and pancreatic intraepithelial neoplasms and the relationship to the expression of p21(WAF1/CIP1). Hermanová M; Lukás Z; Nenutil R; Brázdil J; Kroupová I; Kren L; Pazourková M; Růzicka M; Díte P Neoplasma; 2004; 51(2):77-83. PubMed ID: 15190415 [TBL] [Abstract][Full Text] [Related]
14. High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients. Vimalachandran D; Greenhalf W; Thompson C; Lüttges J; Prime W; Campbell F; Dodson A; Watson R; Crnogorac-Jurcevic T; Lemoine N; Neoptolemos J; Costello E Cancer Res; 2005 Apr; 65(8):3218-25. PubMed ID: 15833853 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma. Henke RT; Haddad BR; Kim SE; Rone JD; Mani A; Jessup JM; Wellstein A; Maitra A; Riegel AT Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6134-42. PubMed ID: 15448000 [TBL] [Abstract][Full Text] [Related]
19. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. Crnogorac-Jurcevic T; Missiaglia E; Blaveri E; Gangeswaran R; Jones M; Terris B; Costello E; Neoptolemos JP; Lemoine NR J Pathol; 2003 Sep; 201(1):63-74. PubMed ID: 12950018 [TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis. Guweidhi A; Kleeff J; Giese N; El Fitori J; Ketterer K; Giese T; Büchler MW; Korc M; Friess H Carcinogenesis; 2004 Sep; 25(9):1575-85. PubMed ID: 15073049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]